Combined treatment with temporary short-term high dose rate iridium-192 brachytherapy and external beam radiotherapy for irradiation of localized prostatic carcinoma

Radiotherapy and Oncology

Volumn 44, Issue 3, 1997, Pages 237-244

  Borghede, Göran ^a   Hedelin, Hans ^a   Holmäng, Sten ^a   Johansson, Karl Axel ^a   Aldenborg, Frank ^a   Pettersson, Silas ^a   Sernbo, Göran ^a   Wallgren, Arne ^a   Mercke, Claes ^a  

^a SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Brachytherapy; Clinical outcome; Localized prostate cancer; Radiotherapy

Indexed keywords

IRIDIUM 192; PROSTATE SPECIFIC ANTIGEN;

ADULT; AGED; ARTICLE; BEAM THERAPY; BRACHYTHERAPY; CANCER SURVIVAL; CLINICAL ARTICLE; CYSTITIS; FOLLOW UP; GASTROINTESTINAL SYMPTOM; HUMAN; HUMAN CELL; HUMAN TISSUE; MALE; PRIORITY JOURNAL; PROSTATE CARCINOMA; RADIATION DOSE; RATING SCALE; SEXUAL DYSFUNCTION; TOXICITY TESTING; TREATMENT OUTCOME; URINE INCONTINENCE;

AGED; BRACHYTHERAPY; DOSE-RESPONSE RELATIONSHIP, DRUG; GASTROINTESTINAL DISEASES; HUMANS; IRIDIUM RADIOISOTOPES; MALE; MIDDLE AGED; NEOPLASM STAGING; PENILE ERECTION; PROSTATE-SPECIFIC ANTIGEN; PROSTATIC NEOPLASMS; RADIATION INJURIES; TREATMENT OUTCOME; URINATION DISORDERS;

EID: 0030813017     PISSN: 01678140     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0167-8140(97)00121-7     Document Type: Article

References (45)

1. Bagshaw, M.A., Cox, R.S. and Ray, G.R. Status of radiation treatment of prostate cancer at Stanford University. Natl. Cancer Inst. Monogr. 7: 47-60, 1988.
2. Blasko, J.C., Radge, H. and Schumacher, D. Transperineal percutaneous iodine-125 implantation for prostatic carcinoma using transrectal ultrasound and template guidance. Endo/Hyperthermia 3: 131-139, 1987.
3. Blasko, J.C., Wallner, K., Grimm, P.D. and Radge, H. Prostate specific antigen based disease control following ultrasound guided iodine-125 implantation for stage T1/T2 prostatic carcinoma. J. Urol. 154: 1096-1099, 1995.
4. Borghede, G., Hedelin, H., Holmäng, S., Johansson, K.A., Sernbo, G. and Mercke, C. Irradiation of localised prostatic carcinoma by a combination of HDR-iridium-192 brachytherapy and external beam radiotherapy with three target definitions and dose levels inside the prostate gland. A technical report. Radiat. Oncol., in press.
5. Bostwick, D.G., Egbert, B.M. and Fajardo, L.F. Radiation injury of the normal and neoplastic prostate. Am. J. Surg. Pathol. 6: 541-551, 1982.
6. Catalona, W.J. and Bigg, S.W. Nerve-sparing radical prostatectomy: evaluation of results after 250 patients, J. Urol. 143: 538-544, 1990.
7. Crusinberry, R.A., Kramolowsky, E.V. and Loening, S.A. Percutaneous transperineal placement of gold-198 seeds for treatment of the carcinoma of the prostate. Prostate 11: 59-67, 1987.
8. Donnelly, B.J., Pedersen, J.E., Porter, A.T. and McPhee, M.S. Iridium-192 brachytherapy in the treatment of cancer of the prostate. Urol. Clin. North Am. 18: 481-483, 1991.
9. Fowler, J.F. The linear-quadratic formula and progress in fractionated radiotherapy. Br. J. Radiol. 62: 679-694, 1989.
10. Freiha, F.S. and Bagshaw, M.A. Carcinoma of the prostate: results of post-irradiation biopsy. Prostate 5: 19-25, 1984.
11. Galalae, R., Kovács, G., Wirth, B., Bertermann, H., Kohr, P. and Kimmg, B. HDR-brachytherapy of NO prostatic cancer combined with high voltage teletherapy: experience with 179 patients (abstract). Eighth International Brachytherapy Conference and Gamma Med Users Meeting, 1995.
12. Grenabo, L., Grundtman, S. and Hedelin, H. Laparoscopic obturator lymph node dissection in patients with prostatic cancer. Scand. J. Urol. Nephrol. 29: 51-55, 1995.
13. Hammer, J. Jod-125-Seed-Implantationen in der Behandlung des Prostatacarzinoms. Strahlenther. Onkol. 167: 63-81, 1991.
14. Hanks, G.E., Martz, K.L. and Diamond, J.J. The effect of dose on local control of the prostatic cancer. Int. J. Radiat. Oncol. Biol. Phys. 15: 1299-1305, 1988.
15. Iversen, P., Bak, M., Juul, N., Laursen, F., von der Maase, H., Nielsen, L., Rasmussen, F., Torp-Pedersen, S. and Holm, H.H. Ultrasonically guided 125 iodine seed implantation with external radiation in management of localized prostatic carcinoma. J. Urol. 34: 181-186, 1989.
16. Johansson, J.E., Adami, H.O., Andersson, S.O., Bergström, R. et al. High 10-year survival rate in patients with early, untreated prostatic cancer. J. Am. Med. Assoc. 267: 2191-2196, 1992.
17. Kaplan, I.D., Cox, R.S. and Bagshaw, M.A. Prostate specific antigen after external beam radiotherapy for prostatic cancer: followup. J. Urol. 149: 519-522, 1993.
18. Kaplan, I.D., Prestidge, B.R., Bagshaw, M.A. and Cox, R.S. The importance of local control in the treatment of prostatic cancer. J. Urol. 147: 917-921, 1992.
19. Kuban, D.A., El-Madhi, A.M. and Schellhammer, P.F. I-125 interstitial implantation for prostate cancer. What have we learned 10 years later? Cancer 63: 2415-2420, 1989.
20. Kuban, D.A., El-Madhi, A.M. and Schellhammer, P. The significance of post-irradiation prostate biopsy with long-term follow-up. Int. J. Radiat. Oncol. Biol. Phys. 24: 409-414, 1992.
21. Lannon, S.G., El-Araby, A.A., Joseph, P.K., Eastwood, B.J. and Awad, S.A. Long-term results of combined interstitial gold seed implantation plus external beam irradiation in localised carcinoma of the prostate. Br. J. Urol. 72: 782-791, 1993.
22. Lawton, C.A., Won, M., Pilipich, M.V., Asbell, S.O., Shipley, W.U., Hanks, G.E., Cox, J.D., Perez, C.A., Sause, W.T., Doggett, S.R.L. and Rubin, P. Long-term treatment sequelae following external beam irradiation for adenocarcinoma of the prostate: analysis of RTOG studies 7506 and 7706. Int. J. Radiat. Oncol. Biol. Phys. 21: 935-939, 1991.
23. Leibel, S.A., Ling, C.C., Kutcher, G.J., Mohan, R., Cordon-Cordo, C. and Fuks, Z. The biological basis for conformal three-dimensional radiation therapy. Int. J. Radiat. Oncol. Biol. Phys. 21: 805-811, 1991.
24. Ling, C.G. Permanent implants using Au-198, Pd-103 and I-125: radiobiological considerations based on the linear quadratic model. Int. J. Radiat. Oncol. Biol. Phys. 23: 81-87, 1992.
25. Ljung, G., Hansson, H., De la Torre, M., Egevad, L., Holmberg, L., Busch, C. and Nilsson, S. Transrectal ultrasonically-guided core biopsies in the assessment of local cure of prostatic cancer after radical external beam radiotherapy. Acta Oncol. 34: 945-952, 1995.
26. Mostofi, F.K., Davis, C.J. and Sesterhenn, I.A. Pathology of carcinoma of the prostate. Cancer 70(Suppl.): 235-253, 1992.
27. Mostofi, F.K., Sesterhenn, I. and Sobin, L.H. International Histologic Classification of Tumours of the Prostate. World Health Organization, 1981.
28. Nisar Syed, A.M., Puthawala, A., Austin, P., Cherlow, J., Perley, J., Tansey, L., Shanberg, A., Sawyer, D., Baghdassarian, R., Wachs, B., Tomasulo, J., Rao, J. and Syed, R. Temporary iridium-192 implant in the management of carcinoma of the prostate. Cancer 69: 2515-2524, 1992.
29. Patel, J., Worthen, R., Abadir, R., Weaver, D.J., Weinstein, S. and Ross, G. Late results of combined iodine-125 and external beam radiotherapy in carcinoma of the prostate. J. Urol. 36: 27-30, 1990.
30. Paulson, D.F. and the uro-oncology research group. The impact of current staging procedures in assessing disease of prostatic adenocarcinoma. J. Urol. 121: 300-302, 1983.
31. Paulson, D.F., Moul, J.W. and Walther, P.J. Radical prostatectomy for clinical stage T1-2 NO MO prostatic carcinoma: long term results. J. Urol. 144: 1180-1184, 1990.
32. Perez, C.A., Lee, H.K., Georgiou, A. and Lockett, M.A. Technical factors affecting morbidity in definitive irradiation for localized carcinoma of the prostate. Int. J. Radiat. Oncol. Biol. Phys. 28: 811-819, 1994.
33. Prestidge, B.R., Butler, E.B., Shaw, D. and McComas, V. Ultrasound guided placement of transperineal prostatic afterloading catheters. Int. J. Radiat. Oncol. Biol. Phys. 28: 263-266, 1994.
34. Pilepich, M.V., Bagshaw, M.A., Asbell, S.O., Hanks, G.E., Krall, J.M., Emami, B.N. and Bard, R.H. Definitive radiotherapy in resectable (stage A2 and B) carcinoma of the prostate - results of a nationwide overview. Int. J. Radiat. Oncol. Biol. Phys. 13: 659-663, 1987.
35. Reddy, E.K., Krishnan, L., Mebust, W., Weigel, J. and Shepherd, G.S. Iridium-192 template therapy in localized prostate cancer. Endo/Hyperthermia 10: 125-129, 1994.
36. Scardino, P.T., Frankel, J.M., Wheeler, T.M., Meacham, R.B., Hoffman, G.S., Seale, C., Wilbanks, J.H., Easley, J. and Carlton, C.E., Jr. The prognostic significance of postirradiation biopsy results in patients with prostatic cancer. J. Urol. 135: 510-516, 1986.
37. Scardino, P.T. and Wheeler, T.M. Local control of prostatic cancer with radiotherapy: frequency and prognostic significance of positive results of postirradiation prostate biopsy. Natl. Cancer Inst. Monogr. 7: 95-103, 1988.
38. Schellhammer, P.F., Kuban, D.A. and El-Madhi, A.M. Local failure after definitive radiation or surgical therapy for carcinoma of the prostate and options for prevention and therapy. Urol. Clin. North Am. 18: 485-499, 1991.
39. Schröder, F.H., Hemanek, P., Denis, L. et al. The TNM classification of prostate carcinoma. Prostate 4 (Suppl.): 129-138, 1992.
40. Schwarzer, J.U., Hofmann, R., Kneschautek, P., Lukas, P., Lindner, A. and Braun, J. High-dose-rate-Brachytherapie des Prostatakarzinoms mit Iridium 192. Strahlenther. Oncol. 168: 17-22, 1992.
41. Stamey, T.A., Ferrari, M.K. and Schmid, H.P. The value of serial prostate specific antigen determinations 5 years after radiotherapy: steeply increasing values characterize 80% of patients. J. Urol. 150: 1856-1859, 1993.
42. Stein, A., deKernion, J.B., Smith, R.B., Dorey, F. and Patel, H. Prostate specific antigen levels after radical prostatectomy in patients with organ confined and locally extensive prostate cancer. J. Urol. 147: 942-946, 1992.
43. Wilt, T.J. and Brawer, M.K. The prostate cancer intervention versus observation trial: a randomized trial comparing radical prostatectomy versus expectant management for the treatment of clinically localized prostate cancer. J. Urol. 152: 1910-1914, 1994.
44. Wallner, K., Roy, J., Zelefsky, M., Fuks, Z. and Harrison, L. Short-term freedom from disease progression after 1-125 prostate implantation. Int. J. Radiat. Oncol. Biol. Phys. 30: 405-409, 1994.
45. Zagars, G.K., von Eschenbach, A.C., Ayala, A.G., Schultheiss, T.E. and Sherman, N.E. The influence of local control on metastatic dissemination of prostatic cancer treated by external beam megavoltage radiation therapy. Cancer 68: 2370-2377, 1991.